dr. A.D. van Zuilen

UMCU/Novartis Transplant Advisory Board
Dept. of Internal Medicine, Division of Nephrology
Utrecht
Netherlands

More information

Presentations of this speaker
Wednesday

4 Mar

0:00 - 0:00h at Toon Hermans Foyer 3. Design of the OPTIMIZE study: OPen label multicenter randomized Trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation S.E. de Boer, J.S.F. Sanders, F.J. Bemelman, A.W. Gomes Neto, L.B. Hilbrands, D. Kuypers, S. P. Berger, S.A. Nurmohamed, H. Bouwsma, A.P.J. de Vries, A.D. van Zuilen, D.A. Hesselink
Wednesday

4 Mar

0:00 - 0:00h at Toon Hermans Foyer 4. LCP-tacrolimus in daily practice: tolerability and intrapatient variability K.L.W. Bunthof, A.D. van Zuilen, J.W. van der Heijden, L.B. Hilbrands
Wednesday

4 Mar

10:55 - 11:00h at Theaterzaal Novartis Transplantation Awards 2020 A.D. van Zuilen
Wednesday

4 Mar

14:20 - 14:30h at Theaterzaal Detrimental consequences of early graft loss after kidney transplantation: conclusions from a nationwide evaluation M.J. de Kok, A.F. Schaapherder, J.W. Mensink, A.P.J. de Vries, M.E.J. Reinders, C. Konijn, F.J. Bemelman, J. van de Wetering, A.D. van Zuilen, M.H.L. Christiaans, M.C. Baas, S.A. Nurmohamed, S. P. Berger, R.J. Ploeg, I.P.J. Alwayn, J.H. Lindeman
Thursday

5 Mar

14:40 - 14:50h at Leo Franssen zaal Induction therapy determines graft and patient survival in ABO-incompatible kidney transplantation A.E. de Weerd, J.A.J.G. van den Brand, H. Bouwsma, A.P.J. de Vries, P.H.M.M. Dooper, J.S.F. Sanders, M. van Dijk, M.H.L. Christiaans, F.E. van Reekum, A.D. van Zuilen, F.J. Bemelman, M.S. van Sandwijk, S.A. Nurmohamed, M. van Agteren, M.G.H. Betjes, M.F.C. de Jong, M.C. Baas